NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · Real-Time Price · USD
1.590
+0.100 (6.71%)
At close: Apr 1, 2026, 4:00 PM EDT
1.590
0.00 (0.00%)
After-hours: Apr 1, 2026, 8:00 PM EDT

NovaBay Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4271132418
Market Cap Growth
1265.61%24120.68%28.50%-42.42%-77.94%-38.23%
Enterprise Value
35.69703.783.722.423.1711.51
Last Close Price
1.5928.203.0135.70341.252306.70
PE Ratio
--7.42-0.24-0.05-0.19-2.51
PS Ratio
---0.220.281.76
PB Ratio
--30.68-22.760.690.381.77
P/TBV Ratio
-0.40-7.08-15.820.260.301.62
P/FCF Ratio
15.86263.07-0.70-0.55-0.59-1.95
P/OCF Ratio
15.86263.07-0.70-0.55-0.60-1.96
EV/Sales Ratio
---0.230.221.13
EV/EBITDA Ratio
--83.40-0.50-0.60-0.23-1.32
EV/EBIT Ratio
--83.40-0.50-0.59-0.22-1.30
EV/FCF Ratio
13.20260.37-0.89-0.58-0.47-1.25
Debt / Equity Ratio
-0.01-0.01-9.370.330.150.03
Debt / EBITDA Ratio
-0.09-0.09-0.23-0.64-0.15-0.06
Debt / FCF Ratio
0.290.29-0.40-0.63-0.30-0.06
Net Debt / Equity Ratio
0.310.31-9.63-0.09-0.31-0.68
Net Debt / EBITDA Ratio
0.850.85-0.170.080.240.80
Net Debt / FCF Ratio
-2.66-2.66-0.300.080.490.75
Asset Turnover
-000.820.710.52
Inventory Turnover
--02.221.991.93
Quick Ratio
6.976.970.150.841.722.66
Current Ratio
7.607.600.681.672.663.83
Return on Equity (ROE)
289.45%289.45%-549.45%-88.62%-102.37%-51.79%
Return on Assets (ROA)
-135.48%-135.48%-118.47%-32.26%-71.41%-45.20%
Return on Invested Capital (ROIC)
-618.92%-618.92%-232.85%-72.81%-140.18%-124.76%
Return on Capital Employed (ROCE)
-199.20%-199.20%-276.57%-48.55%-88.24%-53.81%
Earnings Yield
-51.65%-13.48%-421.96%-1948.74%-517.95%-39.91%
FCF Yield
6.31%0.38%-142.99%-181.64%-170.51%-51.39%
Dividend Yield
-2.93%0.00%0.00%0.00%0.00%
Payout Ratio
--21.76%0.00%0.00%0.00%0.00%
Buyback Yield / Dilution
-757.14%-757.14%-2729.17%-160.87%-29.11%-24.43%
Total Shareholder Return
-757.14%-754.21%-2729.17%-160.87%-29.11%-24.43%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q